{
    "q": [
        {
            "docid": "4109042_18",
            "document": "Cell signaling . In some cases, receptor activation caused by ligand binding to a receptor is directly coupled to the cell's response to the ligand. For example, the neurotransmitter GABA can activate a cell surface receptor that is part of an ion channel. GABA binding to a GABA receptor on a neuron opens a chloride-selective ion channel that is part of the receptor. GABA receptor activation allows negatively charged chloride ions to move into the neuron, which inhibits the ability of the neuron to produce action potentials. However, for many cell surface receptors, ligand-receptor interactions are not directly linked to the cell's response. The activated receptor must first interact with other proteins inside the cell before the ultimate physiological effect of the ligand on the cell's behavior is produced. Often, the behavior of a chain of several interacting cell proteins is altered following receptor activation. The entire set of cell changes induced by receptor activation is called a signal transduction mechanism or pathway.",
            "score": 129.14083647727966
        },
        {
            "docid": "29049734_3",
            "document": "Nematode chemoreceptor . Animals recognise a wide variety of chemicals using their senses of taste and smell. The nematode \"Caenorhabditis elegans\" has only 14 types of chemosensory neuron, yet is able to respond to dozens of chemicals because each neuron detects several stimuli. More than 40 highly divergent transmembrane proteins that could contribute to this functional diversity have been described. Most of the candidate receptor genes are in clusters of similar genes; 11 of these appear to be expressed in small subsets of chemosensory neurons. A single type of neuron can potentially express at least 4 different receptor genes. Some of these might encode receptors for water-soluble attractants, repellents and pheromones, which are divergent members of the G-protein-coupled receptor family. Sequences of the Sra family of C.elegans receptor-like proteins contain 6-7 hydrophobic, putative transmembrane, regions. These can be distinguished from other 7TM proteins (especially those known to couple G-proteins) by their own characteristic TM signatures.",
            "score": 80.75812363624573
        },
        {
            "docid": "29289671_8",
            "document": "Melatonin receptor agonist . When melatonin receptor agonists activate their receptors it causes numerous physiological processes. MT and MT receptors may be a target for the treatment of circadian and non circadian sleep disorders because of their differences in pharmacology and function within the SCN. The SCN is responsible for maintaining the 24 hour cycle which regulates many different body functions ranging from sleep to immune functions. Melatonin receptors have been identified in the cardiovascular system. Evidence from animal studies points to a dual role of melatonin in the vasculature. Activation of MT receptors mediates vasoconstriction and the activation of MT receptors mediates vasodilation. Melatonin is involved in regulating immune responses in both human and animals through activation of both MT and MT receptors. MT and MT receptors are widespread in the eye and are involved in regulating aqueous humor secretion, which is important for glaucoma, and in phototransduction. This is not a complete list since many of the possible processes need further confirmation.",
            "score": 105.01984930038452
        },
        {
            "docid": "896294_6",
            "document": "Paul Greengard . Greengard's research has focused on events inside the neuron caused by neurotransmitters. Specifically, Greengard and his fellow researchers studied the behavior of second messenger cascades that transform the docking of a neurotransmitter with a receptor into permanent changes in the neuron. In a series of experiments, Greengard and his colleagues showed that when dopamine interacts with a receptor on the cell membrane of a neuron, it causes an increase in cyclic AMP inside the cell. This increase of cyclic AMP, in turn activates a protein called protein kinase A, which turns other proteins on or off by adding phosphate groups in a reaction known as phosphorylation. The proteins activated by phosphorylation can then perform a number of changes in the cell: transcribing DNA to make new proteins, moving more receptors to the synapse (and thus increasing the neuron's sensitivity), or moving ion channels to the cell surface (and thus increasing the cell's excitability). He was awarded the Nobel Prize in 2000 \"for showing how neurotransmitters act on the cell and can activate a central molecule known as DARPP-32\".",
            "score": 120.59813737869263
        },
        {
            "docid": "46349526_8",
            "document": "Amita Sehgal . In 2008, Sehgal \"et al.\" discovered the \"sleepless \"gene in fruit flies through insertional mutagenesis. Mutations in the \"sleepless\" gene caused the flies to sleep 80% less than normal flies and live half as long as normal flies. Sehgal \"et al.\" observed flies had extreme loss of sleep when the flies completely lacked the SLEEPLESS protein. Flies with mutations which lowered the level of SLEEPLESS protein had normal levels of sleep, but when the flies were sleep-deprived, they showed abnormal recovery sleep. Sehgal \"et al.\" also found increased stem cell activity within the testes of male flies with mutations in \"sleepless\". The SLEEPLESS protein activates Shaker potassium channels and inhibits nicotinic acetylcholine receptors.",
            "score": 121.33293414115906
        },
        {
            "docid": "33096801_18",
            "document": "Stress in early childhood . In the human body, the steps that lead to the release of glucocorticoids such as cortisol begin with the release of corticotropin releasing hormone (CRH) and arginine vasopressin (AVP). These hormones travel through the blood vessels to the anterior pituitary gland of the brain. At this location, adrenocorticotropic hormone (ACTH) is released. ACTH binds to the receptors in the adrenal glands, which are located atop the kidneys, and this causes the release of cortisol. Cortisol enters the cytoplasm of cells in the body, including the brain. The hormone then reacts with receptors inside of the cell. The activated receptors reach the nucleus of the cells and regulate the transcription of genes. Eventually, the body experiences physiological and behavioral changes. Because cortisol hormone enters the cell\u2019s nucleus, the effects of change take longer to occur, and last for a longer period of time, compared to the hormones of the SAM system. The effect of cortisol depends upon the type of receptor that it interacts with inside of the cell. There are two glucocorticoid receptors; one is the mineralocorticoid receptor (MR) and another is the glucocorticoid receptor (GR). Normally, when cortisol is outside of the brain, it will bind to GRs. When cortisol is within the brain cells, it will bind to GRs and MRs. However, cortisol and other glucocorticoids bind more readily to MRs. Cortisol\u2019s varying affinity toward GR and MR plays an important role in distinguishing between normal and stress responses by the HPA system. When cortisol is in its basal range, more MRs are bound to cortisol than GRs. GRs are predominantly bound when humans wake from sleep or experience stress. Therefore, GRs arbitrate most of the stress effects of cortisol and glucocorticoids in other species, while MRs control most basal effects. Often, cortisol and GR effects oppose the cortisol and MR effects. This leads many researchers to speculate that early childhood (and adult) stress resilience and weakness entail the ratio of MR to GR activation. Research has found that GRs impair neural flexibility and the processes involved in learning and memory. In contrast, MRs increase the synaptic plasticity. Therefore, the effects of frequent and prolonged stress responses from the HPA system may cause detrimental results.",
            "score": 123.99969363212585
        },
        {
            "docid": "13311_3",
            "document": "Hormone . Hormones are used to communicate between organs and tissues for physiological regulation and behavioral activities, such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Hormones affect distant cells by binding to specific receptor proteins in the target cell resulting in a change in cell function. When a hormone binds to the receptor, it results in the activation of a signal transduction pathway that typically activates gene transcription resulting in increased expression of target proteins; non-genomic effects are more rapid, and can be synergistic with genomic effects. Amino acid\u2013based hormones (amines and peptide or protein hormones) are water-soluble and act on the surface of target cells via second messengers; steroid hormones, being lipid-soluble, move through the plasma membranes of target cells (both cytoplasmic and nuclear) to act within their nuclei.",
            "score": 87.84771418571472
        },
        {
            "docid": "4109042_14",
            "document": "Cell signaling . Cells receive information from their neighbors through a class of proteins known as receptors. Notch is a cell surface protein that functions as a receptor. Animals have a small set of genes that code for signaling proteins that interact specifically with Notch receptors and stimulate a response in cells that express Notch on their surface. Molecules that activate (or, in some cases, inhibit) receptors can be classified as hormones, neurotransmitters, cytokines, and growth factors, in general called receptor ligands. Ligand receptor interactions such as that of the Notch receptor interaction, are known to be the main interactions responsible for cell signaling mechanisms and communication.",
            "score": 100.22151684761047
        },
        {
            "docid": "14754086_10",
            "document": "S100A10 . Although the exact mechanism is unclear, p11 protein has shown to be essential in the regulation of serotonin signaling in the brain. Serotonin (5-hydroxytryptamine or 5-HT), is a neurotransmitter found in the central and peripheral nervous systems. It is involved in mechanisms responsible for memory formation and learning, but is most known for its role in the regulation muscle contraction, appetite, sleep, and mood. Varying levels of serotonin found in the brain are associated with the development of mood disorders, such as clinical depression. P11 interacts with the serotonin receptor proteins, 5-HT receptors such as 5-HT, modulating the receptor signal transduction pathways activated by the binding of serotonin. P11 also recruits the cell surface expression of the 5-HT receptor, increasing its concentration at the synapse. This results in more rapid serotonin-dependent activities. 5-HT is involved in the regulation of kinase activity in the central nervous system, phosphorylating target proteins, and facilitating endosomal activities. P11 is coexpressed with 5-HT mRNA and its protein in parts of the brain associated with depression, suggesting that their functions are linked and influence mood.",
            "score": 104.8483657836914
        },
        {
            "docid": "14522499_8",
            "document": "Prostaglandin EP2 receptor . EP is classified as a relaxant type of prostanoid receptor based on its ability, upon activation, to relax certain types of smooth muscle (see Prostaglandin receptors). When initially bound to PGE or any other of its agonists, it mobilizes G proteins containing the Gs alpha subunit (i.e. G\u03b1)-G beta-gamma complexes (i.e. G). The G\u03b1- G complexes dissociate into their G\u03b1 and G subunits which in turn regulate cell signaling pathways. In particular, G\u03b1 stimulates adenyl cyclase to raise cellular levels of cAMP thereby activating PKA; PKA activates various types of signaling molecules such as the transcription factor CREB which lead to different types of functional responses depending on cell type. EP also activates the a) GSK-3 pathway which regulates cell migratory responses and innate immune responses including pro-inflammatory cytokine and interleukin production and b) Beta-catenin pathway which regulates not only cell\u2013cell adhesion but also activates the Wnt signaling pathway which, in turn, stimulates the transcription of genes responsible for regulating cell migration and proliferation. In many of these respects, EP actions resemble those of another type of relaxant prostanoid receptor, EP but differs from the contractile prostanoid receptors, EP and EP receptors which mobilize G proteins containing the G\u03b1-G\u03b2\u03b3 complex. EP also differs from all the other prostaglandin receptors in that it fails to undergo homologous desensitization. That is, following agonist-induced activation, the other prostaglandin (as well as most types of G protein coupled receptors) quickly become desensitized, often internalized, and whether or not internalized, incapable of activating their G protein targets. This effect limits the duration and extent to which agonists can stimulate cells. EP, by failing to become desensitized, is able to function over prolong periods and later time points than other prostaglandin receptors and therefore potentially able to contribute to more delayed and chronic phases of cellular and tissue responses.",
            "score": 107.0649516582489
        },
        {
            "docid": "2246657_8",
            "document": "Androgen receptor . The primary mechanism of action for androgen receptors is direct regulation of gene transcription. The binding of an androgen to the androgen receptor results in a conformational change in the receptor that, in turn, causes dissociation of heat shock proteins, transport from the cytosol into the cell nucleus, and dimerization. The androgen receptor dimer binds to a specific sequence of DNA known as a hormone response element. Androgen receptors interact with other proteins in the nucleus, resulting in up- or down-regulation of specific gene transcription. Up-regulation or activation of transcription results in increased synthesis of messenger RNA, which, in turn, is translated by ribosomes to produce specific proteins. One of the known target genes of androgen receptor activation is the insulin-like growth factor I receptor (IGF-1R). Thus, changes in levels of specific proteins in cells is one way that androgen receptors control cell behavior.",
            "score": 103.55723404884338
        },
        {
            "docid": "6519036_10",
            "document": "Thromboxane receptor . Following its activation of these pathways, the TP receptors's cell-stimulating ability rapidly reverses by a process termed homologous desensitization, i.e. TP is no longer able to mobilize its G protein targets or further stimulate cell function. Subsequently, the \u03b2 but not \u03b1 isoform of TP undergoes receptor internalization. These receptor down regulating events are triggered by the G protein-coupled receptor kinases mobilized during TP receptor activation. TP receptor-independent agents that stimulate cells to activate protein kinases C or protein kinases A can also down-regulate TP in a process termed heterologous desensitization. For example, prostacyclin I2 (PGI2)-induced activation of its prostacyclin receptor (IP) and prostaglandin D2-induced activation of its prostaglandin DP1 receptor cause TP receptor desensitization by activating protein kinases A while prostaglandin F2alpha-induced activation of its prostaglandin F receptor and prostaglandin E2-induced activation of its prostaglandin EP1 receptor receptor desensitizes TP by activating protein kinases C. These desensitization responses serve to limit the action of receptor agonists as well as the overall extent of cell excitation.",
            "score": 102.55665349960327
        },
        {
            "docid": "654168_4",
            "document": "Receptor antagonist . Biochemical receptors are large protein molecules that can be activated by the binding of a ligand such as a hormone or a drug. Receptors can be membrane-bound, as cell surface receptors, or inside the cell as intracellular receptors, such as nuclear receptors including those of the mitochondrion. Binding occurs as a result of non-covalent interactions between the receptor and its ligand, at locations called the binding site on the receptor. A receptor may contain one or more binding sites for different ligands. Binding to the active site on the receptor regulates receptor activation directly. The activity of receptors can also be regulated by the binding of a ligand to other sites on the receptor, as in allosteric binding sites. Antagonists mediate their effects through receptor interactions by preventing agonist-induced responses. This may be accomplished by binding to the active site or the allosteric site. In addition, antagonists may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity to exert their effects.",
            "score": 95.88601088523865
        },
        {
            "docid": "51903_15",
            "document": "Tyrosine kinase . An example of this trigger-system in action is the process by which the formation of erythrocytes is regulated. Mammals possess this system, which begins in the kidneys where the developmental signal is manufactured. The developmental signal, also called a cytokine, is erythropoietin in this case. (Cytokines are key regulators of hematopoietic cell proliferation and differentiation.) Erythropoietin's activity is initiated when hematopoietic cytokine receptors become activated. In erythrocyte regulation, erythropoietin is a protein containing 165 amino acids that plays a role in activating the cytoplasmic protein kinase JAK. The results of some newer research have also indicated that the aforementioned cytokine receptors function with members of the JAK tyrosine kinase family. The cytokine receptors activate the JAK kinases. This then results in the phosphorylation of several signaling proteins located in the cell membrane. This subsequently affects both the stimulation of ligand-mediated receptors and intracellular signaling pathway activation. Substrates for JAK kinases mediate some gene responses and more. The process is also responsible for mediating the production of blood cells. In this case, erythropoietin binds to the corresponding plasma membrane receptor, dimerizing the receptor. The dimer is responsible for activating the kinase JAK via binding. Tyrosine residues located in the cytoplasmic domain of the erythropoietin receptor are consequently phosphorylated by the activated protein kinase JAK. Overall, this is also how a receptor tyrosine kinase might be activated by a ligand to regulate erythrocyte formation.",
            "score": 97.21917223930359
        },
        {
            "docid": "31370780_3",
            "document": "Heterologous desensitisation . This type of desensitization, termed homologous desensitization, leaves a cell transiently unresponsive to agents that activate the desensitized receptor but not to agents that activate other receptors. It commonly occurs with G protein-coupled receptors where it is mediated by the G protein-coupled receptor kinases (GRK) and arestins that are mobilized during the receptor's activation. Homologous desensitization also occurs with cytokine and other types of receptors, such as those of the epidermal growth factor receptor type, but in these cases desensitization is mediated by other types of receptor kinases. Homologous desensitization serves to limit or restrain a cells responses to stimuli. However, some stimuli cause cells to active protein kinase Cs that act to desensitize multiple types of receptors thereby rendering a cell unresponsive to agonists of multiply receptor types. This commonly occurs with G protein coupled receptors (see Protein kinase C#Function); cytokine and other non-G protein couple receptor types may also become heterologously desensitized by agents that activate protein kinase C but, perhaps more commonly, by agents that activate other protein kinases such as mitogen-activated protein kinase (p38 MAP kinase).",
            "score": 93.27252388000488
        },
        {
            "docid": "14522485_9",
            "document": "Prostaglandin EP1 receptor . Studies using animals genetically engineered to lack EP and supplemented by studies using treatment with EP receptor antagonists and agonists indicate that this receptor serves several functions. 1) It mediates hyperalgesia due to EP1 receptors located in the central nervous system but suppresses pain perception due to E located on dorsal root ganglia neurons in rats. Thus, PGE causes increased pain perception when administered into the central nervous system but inhibits pain perception when administered systemically; 2) It promotes colon cancer development in Azoxymethane-induced and APC gene knockout mice. 3) It promotes hypertension in diabetic mice and spontaneously hypertensive rats. 4) It suppresses stress-induced impulsive behavior and social dysfunction in mice by suppressing the activation of Dopamine receptor D1 and Dopamine receptor D2 signaling. 5) It enhances the differentiation of uncommitted T cell lymphocytes to the Th1 cell phenotype and may thereby favor the development of inflammatory rather than allergic responses to immune stimulation in rodents. Studies with human cells indicate that EP serves a similar function on T cells. 6) It may reduce expression of Sodium-glucose transport proteins in the apical membrane or cells of the intestinal mucosa in rodents. 7) It may be differentially involved in etiology of acute brain injuries. Pharmacological inhibition or genetic deletion of EP receptor produce either beneficial of deleterious effects in rodent models of neurological disorders such as ischemic stroke, epileptic seizure, surgically induced brain injury and traumatic brain injury.",
            "score": 137.21823620796204
        },
        {
            "docid": "15214773_3",
            "document": "Death receptor 6 . The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-\u03baB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors. Knockout studies in mice suggested that this gene plays a role in T helper cell activation, and may be involved in inflammation and immune regulation. The DR6 is an alpha-helical integral membrane receptor protein that shows evidence that it has something to do with the inhibition of blood vessels forming on tumors which would allow them to grow larger. Death receptor 6 gets a chemical message and starts a signaling pathway that causes apoptosis, also known as cell death, to occur. It is also expressed in endothelial cells. Tumor cells can induce, through exposition of amyloid precursor protein (APP), DR6-mediated endothelial cell necroptosis allowing tumors metastasis.",
            "score": 118.51587247848511
        },
        {
            "docid": "4109042_20",
            "document": "Cell signaling . A more complex signal transduction pathway is shown in Figure 3. This pathway involves changes of protein\u2013protein interactions inside the cell, induced by an external signal. Many growth factors bind to receptors at the cell surface and stimulate cells to progress through the cell cycle and divide. Several of these receptors are kinases that start to phosphorylate themselves and other proteins when binding to a ligand. This phosphorylation can generate a binding site for a different protein and thus induce protein\u2013protein interaction. In Figure 3, the ligand (called epidermal growth factor (EGF)) binds to the receptor (called EGFR). This activates the receptor to phosphorylate itself. The phosphorylated receptor binds to an adaptor protein (GRB2), which couples the signal to further downstream signaling processes. For example, one of the signal transduction pathways that are activated is called the mitogen-activated protein kinase (MAPK) pathway. The signal transduction component labeled as \"MAPK\" in the pathway was originally called \"ERK,\" so the pathway is called the MAPK/ERK pathway. The MAPK protein is an enzyme, a protein kinase that can attach phosphate to target proteins such as the transcription factor MYC and, thus, alter gene transcription and, ultimately, cell cycle progression. Many cellular proteins are activated downstream of the growth factor receptors (such as EGFR) that initiate this signal transduction pathway.",
            "score": 101.19416177272797
        },
        {
            "docid": "733945_3",
            "document": "Daf-2 . Insulin/IGF-1-like signaling is well-conserved evolutionarily across animal phyla, from single celled organisms to mammals. DAF-2 is the only member of the insulin receptor family in \"C. elegans\" but it corresponds, in form and function, to multiple pathways in humans. The protein predicted from DAF-2's sequence is 35% identical to the human insulin receptor, which regulates metabolism; 34% identical to the IGF-1 receptor, which regulates growth; and 33% identical to the human insulin receptor\u2013related receptor. In \"C. elegans\", the insulin/IGF-1/FOXO pathway is initiated by changes in IGF-1 levels which cause IGF-1 receptors to start a phosphorylation cascade that deactivates the FOXO transcription factor, DAF-16. When not phosphorylated, DAF-16 is active and present in the nucleus. DAF-16 is responsible for up-regulating transcription of about 100 genes that code for cell protecting products such as heat shock proteins and antioxidants. Genetic analysis reveals that the presence of functioning DAF-16 is required to produce the extended lifespan observed in DAF-2 knock-downs. By silencing DAF-16, activation of DAF-2 receptors can ultimately compromise a cell\u2019s ability to mitigate harmful environmental conditions. In most eukaryotes, insulin activates DAF-2 signaling. However, both human insulin and insulin coded for by orthologous genes in \"C. elegans\" inhibit DAF-2 receptors in \"C. elegans\".",
            "score": 104.4411256313324
        },
        {
            "docid": "10995966_11",
            "document": "Prostaglandin DP1 receptor . PGD2 is the most abundant prostanoid in the brains of humans and other mammals and DP1 receptors are located on Arachnoid mater trabecular cells in mouse basal forebrain. The PGD2-DP1 pathway is involved in the regulation of non-rapid eye movement sleep in rodents: infusion of PGD2 into the lateral ventricle of mice or the brain of rats induces an increase in the amount of non-rapid eye movement sleep in wild-type (WT) but not DP1-deficient animals. This sleep-induction appears to involve the DP1-dependent stimulation of adenosine formation and subsequent simulation of the Adenosine A2A receptor by adenosine. In humans, a genetic variant of ADA associated with the reduced metabolism of adenosine to inosine has been reported to deep sleep and SWA during sleep. These studies suggest that DP1 has a similar role in the sleep of humans.",
            "score": 114.25906276702881
        },
        {
            "docid": "6531976_4",
            "document": "Chemokine receptor . Intracellular signaling by chemokine receptors is dependent on neighbouring G-proteins. G-proteins exist as a heterotrimer; they are composed of three distinct subunits. When the molecule GDP is bound to the G-protein subunit, the G-protein is in an inactive state. Following binding of the chemokine ligand, chemokine receptors associate with G-proteins, allowing the exchange of GDP for another molecule called GTP, and the dissociation of the different G protein subunits. The subunit called G\u03b2 activates an enzyme known as Phospholipase C (PLC) that is associated with the cell membrane. PLC cleaves Phosphatidylinositol (4,5)-bisphosphate (PIP2) to form two second messenger molecules called inositol triphosphate (IP3) and diacylglycerol (DAG); DAG activates another enzyme called protein kinase C (PKC), and IP3 triggers the release of calcium from intracellular stores. These events promote many signaling cascades, effecting a cellular response. For example, when CXCL8 (IL-8) binds to its specific receptors, CXCR1 or CXCR2, a rise in intracellular calcium activates the enzyme phospholipase D (PLD) that goes on to initiate an intracellular signaling cascade called the MAP kinase pathway. At the same time the G-protein subunit G\u03b1 directly activates an enzyme called protein tyrosine kinase (PTK), which phosphorylates serine and threonine residues in the tail of the chemokine receptor, causing its desensitisation or inactivation. The initiated MAP kinase pathway activates specific cellular mechanisms involved in chemotaxis, degranulation, release of superoxide anions, and changes in the avidity of cell adhesion molecules called integrins. Chemokines and their receptors play a crucial role in cancer metastatis as they are involved in extravastation, migration, micrometastatis, and angiogenesis. This role of chemokine is strikingly similar to their normal function of localizing leukocytes to an inflammatory site.",
            "score": 83.28137111663818
        },
        {
            "docid": "26798361_5",
            "document": "Martin J. Lohse . While working with Robert Lefkowitz at Duke University he discovered beta-arrestins, proteins that regulate the function of certain cell surface receptors.  He discovered that beta-1 adrenergic receptors and their regulatory G protein-coupled receptor kinases are dysregulated in heart failure. The observation that increased \u03b21-adrenergic receptor levels and signaling cause long-term cardiac damage contributed to the use of beta-blockers in heart failure patients. Further studies by his lab showed that heart failure is accompanied by a specific type of activation of so-called ERK protein kinases (Extracellular signal-regulated kinases). Another regulatory protein, Raf kinase inhibitor protein (RKIP), was shown to exert beneficial effects on cardiac structure and function.  Lohse pioneered the use of optical techniques to determine, where and how fast receptors become activated by hormones and neurotransmitters.",
            "score": 79.02985429763794
        },
        {
            "docid": "14873446_3",
            "document": "KDELR1 . Retention of resident soluble proteins in the lumen of the endoplasmic reticulum (ER) is achieved in both yeast and animal cells by their continual retrieval from the cis-Golgi or a pre-Golgi compartment. Sorting of these proteins is dependent on a C-terminal tetrapeptide signal, usually lys-asp-glu-leu (KDEL) in animal cells and his-asp-glu-leu (HDEL) in \"S. cerevisiae\". This process is mediated by a receptor that recognizes and binds the tetrapeptide-containing protein and then returns it to the ER. In yeast, the sorting receptor is encoded by a single gene, ERD2, which is a seven-transmembrane protein. Unlike yeast, several human homologs of the ERD2 gene, constituting the KDEL receptor gene family, have been described. The protein encoded by this gene was the first member of the family to be identified, and it encodes a protein structurally and functionally similar to the yeast ERD2 gene product. The KDEL receptor mediates the retrieval of misfolded proteins between the ER and the Golgi apparatus. The KDEL receptor functions by binding to endoplasmic reticulum chaperones. These chaperones are recognized by the KDEL receptor in downstream compartments of the ER. Once bound, they are packaged into coat protein complex I vesicles for retrograde transport to the ER. In vitro studies in yeast have revealed that this receptor regulates membrane transport in the early stages of the secretory pathway from ER to the Golgi. An error or mutation in the KDEL receptor disturbs the ER quality control and diseases associated with ER stress are observed.",
            "score": 76.26602149009705
        },
        {
            "docid": "15397097_5",
            "document": "Orexin-A . Orexins are highly excitatory neuropeptides that were first discovered in the brains of rats. It is a peptide that is produced by a very small population of cells in the lateral and posterior hypothalamus. Orexins strongly excite various brain nuclei (neurons) to affect an organism\u2019s wakefulness by affecting their dopamine, norepinephrine, histamine and acetylcholine systems. These systems work together to stabilize the organism\u2019s sleep cycles. Once made, the orexin peptides can bind to the orexin receptor; which is a G protein coupled receptor. This G protein linked receptor senses molecules outside the cell and activates inside signal transduction pathways to elicit cellular responses.",
            "score": 100.24229979515076
        },
        {
            "docid": "1209057_2",
            "document": "Wnt signaling pathway . The Wnt signaling pathways are a group of signal transduction pathways made of proteins that pass signals into a cell through cell surface receptors. Three Wnt signaling pathways have been characterized: the canonical Wnt pathway, the noncanonical planar cell polarity pathway, and the noncanonical Wnt/calcium pathway. All three pathways are activated by binding a Wnt-protein ligand to a Frizzled family receptor, which passes the biological signal to the Dishevelled protein inside the cell. The canonical Wnt pathway leads to regulation of gene transcription, and is thought to be negatively regulated in part by the SPATS1 gene. The noncanonical planar cell polarity pathway regulates the cytoskeleton that is responsible for the shape of the cell. The noncanonical Wnt/calcium pathway regulates calcium inside the cell. Wnt signaling pathways use either nearby cell-cell communication (paracrine) or same-cell communication (autocrine). They are highly evolutionarily conserved in animals, which means they are similar across animal species from fruit flies to humans.",
            "score": 80.5704505443573
        },
        {
            "docid": "152611_11",
            "document": "Cellular differentiation . Each specialized cell type in an organism expresses a subset of all the genes that constitute the genome of that species. Each cell type is defined by its particular pattern of regulated gene expression. Cell differentiation is thus a transition of a cell from one cell type to another and it involves a switch from one pattern of gene expression to another. Cellular differentiation during development can be understood as the result of a gene regulatory network. A regulatory gene and its cis-regulatory modules are nodes in a gene regulatory network; they receive input and create output elsewhere in the network. The systems biology approach to developmental biology emphasizes the importance of investigating how developmental mechanisms interact to produce predictable patterns (morphogenesis). (However, an alternative view has been proposed recently. Based on stochastic gene expression, cellular differentiation is the result of a Darwinian selective process occurring among cells. In this frame, protein and gene networks are the result of cellular processes and not their cause. See: Cellular Darwinism) A few evolutionarily conserved types of molecular processes are often involved in the cellular mechanisms that control these switches. The major types of molecular processes that control cellular differentiation involve cell signaling. Many of the signal molecules that convey information from cell to cell during the control of cellular differentiation are called growth factors. Although the details of specific signal transduction pathways vary, these pathways often share the following general steps. A ligand produced by one cell binds to a receptor in the extracellular region of another cell, inducing a conformational change in the receptor. The shape of the cytoplasmic domain of the receptor changes, and the receptor acquires enzymatic activity. The receptor then catalyzes reactions that phosphorylate other proteins, activating them. A cascade of phosphorylation reactions eventually activates a dormant transcription factor or cytoskeletal protein, thus contributing to the differentiation process in the target cell. Cells and tissues can vary in competence, their ability to respond to external signals.",
            "score": 97.7454423904419
        },
        {
            "docid": "46839881_3",
            "document": "N-2\u2032-Indolylnaltrexamine . INTA acts on the body by binding to a G-protein coupled receptor (GPCR) called the opioid receptor. Opioid Receptors, themselves, are divided into different subunits: kappa (KOR), delta (DOR), and mu (MOR) receptors. When INTA binds to the receptors, it is actually binding to a heteromer of the receptor. This means that it is binding to two of the subunits, instead of just one. These two receptors \"work together\" to form a conformation to block the recruitment of a protein family known as the \u03b2-arrestins. These proteins are responsible for the regulation of GPCR's and they cause the internalization of the receptor to prevent further activation, leading to an increased tolerance to opioid drugs.",
            "score": 62.38865041732788
        },
        {
            "docid": "31009191_22",
            "document": "Microbial cooperation . The integration of cooperative and communicative interactions appear to be extremely important to microbes; for example, 6\u201310% of all genes in the bacterium \"Pseudomonas aeruginosa\" are controlled by cell-cell signaling systems. One way that microbes communicate and organize with each other in order to partake in more advanced cooperative interactions is through quorum sensing. Quorum sensing describes the phenomenon in which the accumulation of signaling molecules in the surrounding environment enables a single cell to assess the number of individuals (cell density) so that the population as a whole can make a coordinated response. This interaction is fairly common among bacterial taxa, and involves the secretion by individual cells of 'signaling' molecules, called autoinducers or pheromones.These bacteria also have a receptor that can specifically detect the signaling molecule. When the inducer binds the receptor, it activates transcription of certain genes, including those for inducer synthesis. There is a low likelihood of a bacterium detecting its own secreted inducer. Thus, in order for gene transcription to be activated, the cell must encounter signaling molecules secreted by other cells in its environment. When only a few other bacteria of the same kind are in the vicinity, diffusion reduces the concentration of the inducer in the surrounding medium to almost zero, so the bacteria produce little inducer. However, as the population grows the concentration of the inducer passes a threshold, causing more inducer to be synthesized. This forms a positive feedback loop, and the receptor becomes fully activated. Activation of the receptor induces the up regulation of other specific genes, causing all of the cells to begin transcription at approximately the same time. In other words, when the local concentration of these molecules has reached a threshold, the cells respond by switching on particular genes. In this way individual cells can sense the local density of bacteria, so that the population as a whole can make a coordinated response.",
            "score": 130.39096307754517
        },
        {
            "docid": "10995966_7",
            "document": "Prostaglandin DP1 receptor . Among the 8 human prostanoid receptors, DP1, along with IP, EP2, and EP4, are classified as relaxant prostanoid receptors; each, including DP1, is a G protein-coupled receptors that works by activating G-S proteins which in turn raises cellular cAMP levels thereby mobilizing Cyclic adenosine monophosphate-activated cell signaling pathways which regulate cell function. DP1 activation also causes the mobilization of calcium in HEK293 cells transfected with this receptor. It does so by a mechanism that is independent of Inositol trisphosphate signaling; Ligand-activated DP1 also mobilizes G protein-coupled receptor kinase 2 (GRK2, also known as \u03b2-Adrenergic receptor kinase 2 [BARK1]) and arrestin 2 (also known as Arrestin beta 1 [ARRB1]). These agents act to uncouple DP1 from its G proteins and to internalize in a process that limits the DP1's cell-activation life-time in a process termed homologous desensitization. Activation of protein kinase Cs likewise trigger DP1 to uncouple from G proteins and internalize although in model studies DP1 has not been shown to cause the activation of PKC (see Protein kinase C#Function).",
            "score": 93.25182938575745
        },
        {
            "docid": "5326585_9",
            "document": "Systemin . Exceedingly small amounts of tomato systemin are active, femto-molar concentrations of the peptide are sufficient to elicit a response at the whole plant level, making it one of the most potent gene activators identified. A receptor for tomato systemin was identified as a 160KDa leucine-rich repeat receptor like kinase (LRR-RLK), SR160. After being isolated it was found that was very similar in structure to BRI1 from \"A. thaliana\", the receptor that brassinolides bind to on the cell membrane. This was the first receptor which was found to be able to bind both a steroid and a peptide ligand and also to be involved in both defensive and developmental responses. Recent studies have found that the initial conclusion that BRI1 is the receptor for tomato systemin may be incorrect. In \"cu3\" mutants of tomato, a null allele with a stop codon present in the extracellular LRR domain of BRI1 prevents the receptor from being localised correctly and it also lacks the kinase domain, required for signalling. These mutants are insensitive to brassinolide yet still respond to tomato systemin by producing protease inhibitors and causing an alkalisation response. This led Holton \"et al.\" to suggest that there is another mechanism by which systemin is perceived. Further investigation showed that binding of systemin to BRI1 does not cause the receptor to become phosphorylated, as when brassinolides bind, suggesting that it does not transduce a signal. When BRI1 is silenced in tomato, the plants have a similar phenotype to \"cu3\" mutants yet are still able to respond normally to systemin, strengthening the view that BRI1 is not the systemin receptor.",
            "score": 91.80116319656372
        },
        {
            "docid": "2121098_9",
            "document": "Aftertaste . In the context of aftertaste, the combination of both receptor-dependent and receptor-independent processes have been proposed to explain the signal transduction mechanisms for foods with distinct aftertastes, particularly those that are bitter. The receptor-dependent process is the same as what was described above. However, the receptor-independent process involves the diffusion of bitter, amphiphilic chemicals like quinine across the taste receptor cell membranes. Once inside the taste receptor cell, these compounds have been observed to activate intracellular G-proteins and other proteins that are involved in signaling pathways routed to the brain. The bitter compounds thus activate both the taste receptors on the cell surface, as well as the signaling pathway proteins in the intracellular space. Intracellular signaling may be slower than taste cell receptor activation since more time is necessary for the bitter compounds to diffuse across the cell membrane and interact with intracellular proteins. This delayed activation of intracellular signaling proteins in response to the bitter compounds, in addition to the extracellular receptor signaling is proposed to be related to the lingering aftertaste associated with bitter foods. The combination of both mechanisms leads to an overall longer response of the taste receptor cells to the bitter foods, and aftertaste perception subsequently occurs.",
            "score": 107.70313346385956
        },
        {
            "docid": "14429376_7",
            "document": "Prostaglandin DP2 receptor . G protein-coupled receptors (GPCRs) such as DP are integral membrane proteins that, when bound by their cognate ligands (or, in some cases, even when not ligand-bound and thereby acting continuously in a constitutive manner {see Receptor (biochemistry)#Constitutive activity}), mobilize one or more types of Heterotrimeric G proteins. DP is classified as a \"contractile\" prostanoid receptor in that it can cause the contraction of smooth muscle. As evidenced by its initial discovery as a receptor for PGD in T-helper type 2 cells, activated DP triggers Gi alpha subunit-linked heterotrimeric G proteins to dissociate into their component a) Gi alpha subunits (also termed Gi subunits) which simulate phospholipase C to cleave phosphatidylinositol triphosphate into inositol triphosphate (IP3) and diacylglycerol (DAG) and b) G beta-gamma complex of subunits (G) which inhibit adenyl cyclase. IP3 raises cytosolic Ca levels thereby regulating Ca-sensitive signal pathways; DAG activates certain protein kinase C enzymes )PKCs) that phosphorylate and thereby regulate target proteins involved in cell signaling; and adenyl cyclase converts AMP into cyclic AMP (cAMP) thereby down-regulating cAMP-responsive proteins involved in cell signalling. Concurrently with the mobilization of these pathways, activated DP also mobilizes G protein-coupled receptor kinases (GPKs, GPK2, GPK5, and/or GPK6) and Arrestin-2 (also termed Arrestin beta 1 or \u03b2-arrestin). The GPKs, along with the DAG-activated PKCs, phosphorylate DP to promote its internalization while arrestin-2 inhibits DP from further activating heterotrimeric G proteins while also linking DP to elements, clathrin and clathrin adaptor AP2, of the receptor internalization machinery. These pathways render DP unable to mobilize heterotrimereic G proteins thereby rendering the cell less sensitive or insensitive to further stimulation by DP ligands. The process, termed Homologous desensitization, serves as a physiological limiter of cell responses to DP activators.",
            "score": 92.41313815116882
        }
    ],
    "r": [
        {
            "docid": "29583863_9",
            "document": "Simon Gaskell . In recent years, international efforts have been made to sequence the genomes of many organisms, including man. These studies of an organism\u2019s entire DNA sequence (known as genomics) have in turn led to the development of a similar field of research, called \u2018proteomics\u2019. Proteomics is the study of the structure and function of a cell\u2019s entire set of proteins, which orchestrate the chemical reactions that occur within cells. To understand how a cell works, scientists need to know which proteins are present and in what amounts. Gaskell\u2019s research uses various forms of an analytical technique called mass spectrometry to determine the quantity and longevity of these different proteins. Gaskell has recently used these techniques to study a human parasite called \"Trypanosoma Brucei\". It causes sleeping sickness, which affects around 400,000 people each year, predominantly in the developing world.",
            "score": 138.46200561523438
        },
        {
            "docid": "14522485_9",
            "document": "Prostaglandin EP1 receptor . Studies using animals genetically engineered to lack EP and supplemented by studies using treatment with EP receptor antagonists and agonists indicate that this receptor serves several functions. 1) It mediates hyperalgesia due to EP1 receptors located in the central nervous system but suppresses pain perception due to E located on dorsal root ganglia neurons in rats. Thus, PGE causes increased pain perception when administered into the central nervous system but inhibits pain perception when administered systemically; 2) It promotes colon cancer development in Azoxymethane-induced and APC gene knockout mice. 3) It promotes hypertension in diabetic mice and spontaneously hypertensive rats. 4) It suppresses stress-induced impulsive behavior and social dysfunction in mice by suppressing the activation of Dopamine receptor D1 and Dopamine receptor D2 signaling. 5) It enhances the differentiation of uncommitted T cell lymphocytes to the Th1 cell phenotype and may thereby favor the development of inflammatory rather than allergic responses to immune stimulation in rodents. Studies with human cells indicate that EP serves a similar function on T cells. 6) It may reduce expression of Sodium-glucose transport proteins in the apical membrane or cells of the intestinal mucosa in rodents. 7) It may be differentially involved in etiology of acute brain injuries. Pharmacological inhibition or genetic deletion of EP receptor produce either beneficial of deleterious effects in rodent models of neurological disorders such as ischemic stroke, epileptic seizure, surgically induced brain injury and traumatic brain injury.",
            "score": 137.21823120117188
        },
        {
            "docid": "546712_5",
            "document": "Neurotoxicity . A\u03b2 was found to cause neurotoxicity and cell death in the brain when present in high concentrations. A\u03b2 results from a mutation that occurs when protein chains are cut at the wrong locations, resulting in chains of different lengths that are unusable. Thus they are left in the brain until they are broken down, but if enough accumulate, they form plaques which are toxic to neurons. A\u03b2 uses several routes in the central nervous system to cause cell death. An example is through the nicotinic acetylcholine receptor (nAchRs), which is a receptor commonly found along the surfaces of the cells that respond to nicotine stimulation, turning them on or off. A\u03b2 was found manipulating the level of nicotine in the brain along with the MAP kinase, another signaling receptor, to cause cell death. Another chemical in the brain that A\u03b2 regulates is JNK; this chemical halts the extracellular signal-regulated kinases (ERK) pathway, which normally functions as memory control in the brain. As a result, this memory favoring pathway is stopped, and the brain loses essential memory function. The loss of memory is a symptom of neurodegenerative disease, including AD. Another way A\u03b2 causes cell death is through the phosphorylation of AKT; this occurs as the element phosphate is bound to several sites on the protein. This phosphorylation allows AKT to interact with BAD, a protein known to cause cell death. Thus an increase in A\u03b2 results in an increase of the AKT/BAD complex, in turn stopping the action of the anti-apoptotic protein Bcl-2, which normally functions to stop cell death, causing accelerated neuron breakdown and the progression of AD.",
            "score": 135.14036560058594
        },
        {
            "docid": "276251_14",
            "document": "Orexin . The discovery that an orexin receptor mutation causes the sleep disorder canine narcolepsy in Doberman Pinschers subsequently indicated a major role for this system in sleep regulation. Genetic knockout mice lacking the gene for orexin were also reported to exhibit narcolepsy. Transitioning frequently and rapidly between sleep and wakefulness, these mice display many of the symptoms of narcolepsy. Researchers are using this animal model of narcolepsy to study the disease. Narcolepsy results in excessive daytime sleepiness, inability to consolidate wakefulness in the day (and sleep at night), and cataplexy, which is the loss of muscle tone in response to strong, usually positive, emotions. Dogs that lack a functional receptor for orexin have narcolepsy, while animals and people lacking the orexin neuropeptide itself also have narcolepsy.",
            "score": 134.82742309570312
        },
        {
            "docid": "18835541_2",
            "document": "Narcolepsy . Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of those affected also experience episodes of sudden loss of muscle strength, known as cataplexy. These experiences can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse. The exact cause of narcolepsy is unknown, with potentially several causes. In up to 10% of cases, there is a family history of the disorder. Often, those affected have low levels of the neuropeptide \"orexin\", which may be due to an autoimmune disorder. Trauma, infections, toxins or psychological stress may also play a role. Diagnosis is typically based on the symptoms and sleep studies, after ruling out other potential causes. Excessive daytime sleepiness can also be caused by other sleep disorders such as sleep apnea, major depressive disorder, anemia, heart failure, drinking alcohol and not getting enough sleep. Cataplexy may be mistaken for seizures. While there is no cure, a number of lifestyle changes and medications may help. Lifestyle changes include taking regular short naps and sleep hygiene. Medications used include modafinil, sodium oxybate and methylphenidate. While initially effective, tolerance to the benefits may develop over time. Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) may improve cataplexy. About 0.2 to 600 per 100,000 people are affected. The condition often begins in childhood. Men and women are affected equally. Untreated narcolepsy increases the risk of motor vehicle collisions and falls. The term \"narcolepsy\" is from the French \"narcolepsie\". The French term was first used in 1880 by Jean-Baptiste-\u00c9douard G\u00e9lineau, who used the Greek \u03bd\u03ac\u03c1\u03ba\u03b7 (\"nark\u0113\"), meaning \"numbness\", and \u03bb\u1fc6\u03c8\u03b9\u03c2 (\"lepsis\") meaning \"attack\". There are two main characteristics of narcolepsy: excessive daytime sleepiness and abnormal REM sleep. The first, excessive daytime sleepiness (EDS), occurs even after adequate night time sleep. A person with narcolepsy is likely to become drowsy or fall asleep, often at inappropriate times and places, or just be very tired throughout the day. Narcoleptics are not able to experience the amount of restorative deep sleep that healthy people experience \u2013 they are not \"over-sleeping\". In fact, narcoleptics live their entire lives in a constant state of extreme sleep deprivation.",
            "score": 134.5677490234375
        },
        {
            "docid": "52649_2",
            "document": "Acetylcholine . Acetylcholine (ACh) is an organic chemical that functions in the brain and body of many types of animals, including humans, as a neurotransmitter\u2014a chemical message released by nerve cells to send signals to other cells [neurons, muscle cells, and gland cells]. Its name is derived from its chemical structure: it is an ester of acetic acid and choline. Parts in the body that use or are affected by acetylcholine are referred to as cholinergic. Substances that interfere with acetylcholine activity are called anticholinergics. Acetylcholine is the neurotransmitter used at the neuromuscular junction\u2014in other words, it is the chemical that motor neurons of the nervous system release in order to activate muscles. This property means that drugs that affect cholinergic systems can have very dangerous effects ranging from paralysis to convulsions. Acetylcholine is also used as a neurotransmitter in the autonomic nervous system, both as an internal transmitter for the sympathetic nervous system and as the final product released by the parasympathetic nervous system.",
            "score": 131.08763122558594
        },
        {
            "docid": "31009191_22",
            "document": "Microbial cooperation . The integration of cooperative and communicative interactions appear to be extremely important to microbes; for example, 6\u201310% of all genes in the bacterium \"Pseudomonas aeruginosa\" are controlled by cell-cell signaling systems. One way that microbes communicate and organize with each other in order to partake in more advanced cooperative interactions is through quorum sensing. Quorum sensing describes the phenomenon in which the accumulation of signaling molecules in the surrounding environment enables a single cell to assess the number of individuals (cell density) so that the population as a whole can make a coordinated response. This interaction is fairly common among bacterial taxa, and involves the secretion by individual cells of 'signaling' molecules, called autoinducers or pheromones.These bacteria also have a receptor that can specifically detect the signaling molecule. When the inducer binds the receptor, it activates transcription of certain genes, including those for inducer synthesis. There is a low likelihood of a bacterium detecting its own secreted inducer. Thus, in order for gene transcription to be activated, the cell must encounter signaling molecules secreted by other cells in its environment. When only a few other bacteria of the same kind are in the vicinity, diffusion reduces the concentration of the inducer in the surrounding medium to almost zero, so the bacteria produce little inducer. However, as the population grows the concentration of the inducer passes a threshold, causing more inducer to be synthesized. This forms a positive feedback loop, and the receptor becomes fully activated. Activation of the receptor induces the up regulation of other specific genes, causing all of the cells to begin transcription at approximately the same time. In other words, when the local concentration of these molecules has reached a threshold, the cells respond by switching on particular genes. In this way individual cells can sense the local density of bacteria, so that the population as a whole can make a coordinated response.",
            "score": 130.39096069335938
        },
        {
            "docid": "4109042_18",
            "document": "Cell signaling . In some cases, receptor activation caused by ligand binding to a receptor is directly coupled to the cell's response to the ligand. For example, the neurotransmitter GABA can activate a cell surface receptor that is part of an ion channel. GABA binding to a GABA receptor on a neuron opens a chloride-selective ion channel that is part of the receptor. GABA receptor activation allows negatively charged chloride ions to move into the neuron, which inhibits the ability of the neuron to produce action potentials. However, for many cell surface receptors, ligand-receptor interactions are not directly linked to the cell's response. The activated receptor must first interact with other proteins inside the cell before the ultimate physiological effect of the ligand on the cell's behavior is produced. Often, the behavior of a chain of several interacting cell proteins is altered following receptor activation. The entire set of cell changes induced by receptor activation is called a signal transduction mechanism or pathway.",
            "score": 129.14083862304688
        },
        {
            "docid": "21944_4",
            "document": "Nervous system . Nervous systems are found in most multicellular animals, but vary greatly in complexity. The only multicellular animals that have no nervous system at all are sponges, placozoans, and mesozoans, which have very simple body plans. The nervous systems of the radially symmetric organisms ctenophores (comb jellies) and cnidarians (which include anemones, hydras, corals and jellyfish) consist of a diffuse nerve net. All other animal species, with the exception of a few types of worm, have a nervous system containing a brain, a central cord (or two cords running in parallel), and nerves radiating from the brain and central cord. The size of the nervous system ranges from a few hundred cells in the simplest worms, to around 300 billion cells in African elephants.",
            "score": 128.742919921875
        },
        {
            "docid": "10534087_66",
            "document": "Serotonin\u2013norepinephrine\u2013dopamine reuptake inhibitor . 5-Hydroxytryptamine (5-HT or serotonin) is an important cell-to-cell signaling molecule found in all animal phyla. In mammals, substantial concentrations of 5-HT are present in the central and peripheral nervous systems, gastrointestinal tract and cardiovascular system. 5-HT is capable of exerting a wide variety of biological effects by interacting with specific membrane-bound receptors, and at least 13 distinct 5-HT receptor subtypes have been cloned and characterized. With the exception of the 5-HT receptor subtype, which is a transmitter-gated ion channel, 5-HT receptors are members of the 7-transmembrane G protein-coupled receptor superfamily. In humans, the serotonergic system is implicated in various physiological processes such as sleep-wake cycles, maintenance of mood, control of food intake and regulation of blood pressure. In accordance with this, drugs that affect 5-HT-containing cells or 5-HT receptors are effective treatments for numerous indications, including depression, anxiety, obesity, nausea, and migraine.",
            "score": 128.29238891601562
        },
        {
            "docid": "3113497_38",
            "document": "Innate immune system . Most plant immune responses involve systemic chemical signals sent throughout a plant. Plants use pattern-recognition receptors to recognize conserved microbial signatures. This recognition triggers an immune response. The first plant receptors of conserved microbial signatures were identified in rice (XA21, 1995) and in Arabidopsis (FLS2, 2000). Plants also carry immune receptors that recognize highly variable pathogen effectors. These include the NBS-LRR class of proteins. When a part of a plant becomes infected with a microbial or viral pathogen, in case of an incompatible interaction triggered by specific elicitors, the plant produces a localized hypersensitive response (HR), in which cells at the site of infection undergo rapid programmed cell death to prevent the spread of the disease to other parts of the plant. HR has some similarities to animal pyroptosis, such as a requirement of caspase-1-like proteolytic activity of VPE\u03b3, a cysteine protease that regulates cell disassembly during cell death.",
            "score": 128.11842346191406
        },
        {
            "docid": "13876671_4",
            "document": "Gliotransmitter . The word \u201cglia\u201d illustrates the original belief among scientists that these cells play a passive role in neural signaling, being responsible only for neuronal structure and support within the brain. Glial cells cannot produce action potentials and therefore were not suspected as playing an important and active communicative role in the central nervous system, because synaptic transmission between neurons is initiated with an action potential. However, research shows that these cells express excitability with changes in the intracellular concentrations of Ca. Gliotransmission occurs because of the ability of glial cells to induce excitability with variations in Ca concentrations. Changes in the concentration of Ca correlate with currents from NMDA receptor-mediated neurons which are measured in neighboring neurons of the ventrobasal (VB) thalamus. Because glial cells greatly outnumber neurons in the brain, accounting for over 70% of all cells in the central nervous system, gliotransmitters released by astrocytes have the potential to be very influential and important within the central nervous system, as well as within other neural systems throughout the body. These cells do not simply carry functions of structural support, but can also take part in cell-to-cell communication with neurons, microglia, and other astrocytes by receiving inputs, organizing information, and sending out chemical signals. The Ca signal from the astrocyte may also participate in controlling blood flow in the brain.",
            "score": 127.85639190673828
        },
        {
            "docid": "38262758_3",
            "document": "Hes3 signaling axis . Cells in tissues need to be able to sense and interpret changes in their environment. For example, cells must be able to detect when they are in physical contact with other cells in order to regulate their growth and avoid the generation of tumors (\u201ccarcinogenesis\u201d). In order to do so, cells place receptor molecules on their surface, often with a section of the receptor exposed to the outside of the cell (extracellular environment), and a section inside the cell (intracellular environment). These molecules are exposed to the environment outside of the cell and, therefore, in position to sense it. They are called receptors because when these come into contact with particular molecules (termed ligands), then chemical changes are induced to the receptor. These changes typically involve alterations in the three-dimensional shape of the receptor. These 3D structure changes affect both the extracellular and intracellular parts (domains) of the receptor. As a result, interaction of a receptor with its specific ligand which is located outside of the cell causes changes to the receptor part which is inside the cell. A signal from the extracellular space, therefore, can affect the biochemical state inside the cell.",
            "score": 126.84503173828125
        },
        {
            "docid": "12134485_5",
            "document": "Nuclear receptor related-1 protein . While NURR1 is a key protein, there are other factors required as research shows that solely expressing NURR1 fails to stimulate this phenotypic gene expression. One of these suggested factors is winged-helix transcription factor 2 (Foxa2). Studies have found these two factors to be within the same region of developing dopaminergic neurons, both of these factors were present in order to have expression for the dopamine phenotype.  Research has been conducted on Nurr1\u2019s role in inflammation, and may provide important information in treating disorders caused by dopaminergic neuron disease. Inflammation in the CNS can result from activated microglia (macrophage analogs for the central nervous system) and other pro-inflammatory factors, such as bacterial lipopolysaccharide (LPS). LPS binds to toll-like receptors (TLR), which induces inflammatory gene expression by promoting signal-dependent transcription factors. To determine which cells are dopaminergic, experiments measured the enzyme tyrosine hydroxylase (TH), which is needed for dopamine synthesis. It has been shown that Nurr1 protects dopaminergic neurons from LPS-induced inflammation, by reducing inflammatory gene expression in microglia and astrocytes. When a short hairpin for Nurr1 was expressed in microglia and astrocytes, these cells produced inflammatory mediators, such as TNFa, NO synthase and IL-1\u03b2, supporting the conclusion that reduced Nurr1 promotes inflammation and leads to cell death of dopaminergic neurons. Nurr1 interacts with the transcription factor complex NF-\u03baB-p65 on the inflammatory gene promoters. However, Nurr1 is dependent on other factors to be able to participate in these interactions. Nurr1 needs to be sumoylated and its co-regulating factor, glycogen synthase kinase 3, needs to be phosphorylated for these interactions to occur. Sumolyated Nurr1 recruits CoREST, a complex made of several proteins that assembles chromatin-modifying enzymes. The Nurr1/CoREST complex inhibits transcription of inflammatory genes.",
            "score": 126.60071563720703
        },
        {
            "docid": "21944_31",
            "document": "Nervous system . Synapses may be electrical or chemical. Electrical synapses make direct electrical connections between neurons, but chemical synapses are much more common, and much more diverse in function. At a chemical synapse, the cell that sends signals is called presynaptic, and the cell that receives signals is called postsynaptic. Both the presynaptic and postsynaptic areas are full of molecular machinery that carries out the signalling process. The presynaptic area contains large numbers of tiny spherical vessels called synaptic vesicles, packed with neurotransmitter chemicals. When the presynaptic terminal is electrically stimulated, an array of molecules embedded in the membrane are activated, and cause the contents of the vesicles to be released into the narrow space between the presynaptic and postsynaptic membranes, called the synaptic cleft. The neurotransmitter then binds to receptors embedded in the postsynaptic membrane, causing them to enter an activated state. Depending on the type of receptor, the resulting effect on the postsynaptic cell may be excitatory, inhibitory, or modulatory in more complex ways. For example, release of the neurotransmitter acetylcholine at a synaptic contact between a motor neuron and a muscle cell induces rapid contraction of the muscle cell. The entire synaptic transmission process takes only a fraction of a millisecond, although the effects on the postsynaptic cell may last much longer (even indefinitely, in cases where the synaptic signal leads to the formation of a memory trace).",
            "score": 126.37153625488281
        },
        {
            "docid": "10548472_36",
            "document": "Neonicotinoid . Neonicotinoids, like nicotine, bind to nicotinic acetylcholine receptors (nAChRs) of a cell and trigger a response by that cell. In mammals, nicotinic acetylcholine receptors are located in cells of both the central nervous system and peripheral nervous systems. In insects these receptors are limited to the central nervous system. Nicotinic acetylcholine receptors are activated by the neurotransmitter acetylcholine. While low to moderate activation of these receptors causes nervous stimulation, high levels overstimulate and block the receptors, causing paralysis and death. Acetylcholinesterase breaks down acetylcholine to terminate signals from these receptors. However, acetylcholinesterase cannot break down neonicotinoids and their binding is irreversible.",
            "score": 126.13577270507812
        },
        {
            "docid": "489289_2",
            "document": "Chemoreceptor . A chemoreceptor, also known as chemosensor, is a specialized sensory receptor cell which transduces (responds to) a chemical substance (endogenous or induced) and generates a biological signal. This signal may be in the form of an action potential if the chemoreceptor is a neuron (nerve cell), or in the form of a neurotransmitter that can activate a nearby nerve fiber if the chemosensor is a specialized sensory receptor cell, such as the taste receptor in a taste bud or in an internal peripheral chemoreceptor such as the carotid body (ex, in chemotherapy). In more general terms, a chemosensor detects toxic or hazardous chemicals in the internal or external environment of the human body (e.x. chemotherapy) and transmits that information to the central nervous system, (and rarely the peripheral nervous system), in order to expel the biologically active toxins from the blood, and prevent further consumption of alcohol and/or other acutely toxic recreational intoxicants.",
            "score": 125.88121032714844
        },
        {
            "docid": "33096801_18",
            "document": "Stress in early childhood . In the human body, the steps that lead to the release of glucocorticoids such as cortisol begin with the release of corticotropin releasing hormone (CRH) and arginine vasopressin (AVP). These hormones travel through the blood vessels to the anterior pituitary gland of the brain. At this location, adrenocorticotropic hormone (ACTH) is released. ACTH binds to the receptors in the adrenal glands, which are located atop the kidneys, and this causes the release of cortisol. Cortisol enters the cytoplasm of cells in the body, including the brain. The hormone then reacts with receptors inside of the cell. The activated receptors reach the nucleus of the cells and regulate the transcription of genes. Eventually, the body experiences physiological and behavioral changes. Because cortisol hormone enters the cell\u2019s nucleus, the effects of change take longer to occur, and last for a longer period of time, compared to the hormones of the SAM system. The effect of cortisol depends upon the type of receptor that it interacts with inside of the cell. There are two glucocorticoid receptors; one is the mineralocorticoid receptor (MR) and another is the glucocorticoid receptor (GR). Normally, when cortisol is outside of the brain, it will bind to GRs. When cortisol is within the brain cells, it will bind to GRs and MRs. However, cortisol and other glucocorticoids bind more readily to MRs. Cortisol\u2019s varying affinity toward GR and MR plays an important role in distinguishing between normal and stress responses by the HPA system. When cortisol is in its basal range, more MRs are bound to cortisol than GRs. GRs are predominantly bound when humans wake from sleep or experience stress. Therefore, GRs arbitrate most of the stress effects of cortisol and glucocorticoids in other species, while MRs control most basal effects. Often, cortisol and GR effects oppose the cortisol and MR effects. This leads many researchers to speculate that early childhood (and adult) stress resilience and weakness entail the ratio of MR to GR activation. Research has found that GRs impair neural flexibility and the processes involved in learning and memory. In contrast, MRs increase the synaptic plasticity. Therefore, the effects of frequent and prolonged stress responses from the HPA system may cause detrimental results.",
            "score": 123.99969482421875
        },
        {
            "docid": "4617112_31",
            "document": "Endocannabinoid system . Increased endocannabinoid signaling within the central nervous system promotes sleep-inducing effects. Intercerebroventricular administration of anandamide in rats has been shown to decrease wakefulness and increase slow-wave sleep and REM sleep. Administration of anandamide into the basal forebrain of rats has also been shown to increase levels of adenosine, which plays a role in promoting sleep and suppressing arousal. REM sleep deprivation in rats has been demonstrated to increase CB1 receptor expression in the central nervous system. Furthermore, anandamide levels possess a circadian rhythm in the rat, with levels being higher in the light phase of the day, which is when rats are usually asleep or less active, since they are nocturnal.",
            "score": 123.82905578613281
        },
        {
            "docid": "45621_18",
            "document": "Psychopharmacology . Hypnotics are often used to treat the symptoms of insomnia, or other sleep disorders. Benzodiazepines are still among the most widely prescribed sedative-hypnotics in the United States today. Certain non-benzodiazepine drugs are used as hypnotics as well. Although they lack the chemical structure of the benzodiazepines, their sedative effect is similarly through action on the GABAA receptor. They also have a reputation of being less addictive than benzodiazepines. Melatonin, a naturally-occurring hormone, is often used over the counter (OTC) to treat insomnia and jet lag. This hormone appears to be excreted by the pineal gland early during the sleep cycle and may contribute to human circadian rhythms. Because OTC melatonin supplements are not subject to careful and consistent manufacturing, more specific melatonin agonists are sometimes preferred. They are used for their action on melatonin receptors in the suprachiasmatic nucleus, responsible for sleep-wake cycles. Many barbiturates have or had an FDA-approved indication for use as sedative-hypnotics, but have become less widely used because of their limited safety margin in overdose, their potential for dependence, and the degree of central nervous system depression they induce. The amino-acid L-tryptophan is also available OTC, and seems to be free of dependence or abuse liability. However, it is not as powerful as the traditional hypnotics. Because of the possible role of serotonin in sleep patterns, a new generation of 5-HT antagonists are in current development as hypnotics.",
            "score": 123.1778793334961
        },
        {
            "docid": "27622452_4",
            "document": "Julian Jack . Jack studies how nerve cells, or neurons, communicate with one another in the nervous system. He is also interested in understanding how chemical and electrical signals move through neural networks, such as the spinal cord or cerebral cortex. Although neurons form large networks, these cells do not actually touch each other. Instead, when the end of a nerve is activated it releases ions or chemicals known as neurotransmitters. Subsequently, these move across the gap, or synapse, between the neuron and the adjacent cell in the network, activating its receptors and perpetuating the signal. Jack applies theoretical and experimental approaches to research this process of synaptic transmission. This includes the use of neurophysiology methods to record bioelectrical activity and mathematical models to analyse the central and peripheral nervous systems. His work on neurotransmission is offering insight into disorders of the nervous system, such as Alzheimer\u2019s disease and multiple sclerosis, and has the potential to improve their diagnosis.",
            "score": 122.9743423461914
        },
        {
            "docid": "6019108_10",
            "document": "FLP-FRT recombination . Because the recombination activity can be targeted to a selected organ, or a low level of recombination activity can be used to consistently alter the DNA of only a subset of cells, Flp-\"FRT\" can be used to construct genetic mosaics in multicellular organisms. Using this technology, the loss or alteration of a gene can be studied in a given target organ of interest, even in cases where experimental animals would not survive the loss of this gene in other organs(\"spatial control\"). The effect of altering a gene can also be studied over time, by using an inducible promoter to trigger the recombination activity late in development (\"temporal control\") - this prevents the alteration.",
            "score": 122.09215545654297
        },
        {
            "docid": "52316_11",
            "document": "Mood disorder . The long-term use of benzodiazepines may have a similar effect on the brain as alcohol, and are also implicated in depression. As with alcohol, the effects of benzodiazepine on neurochemistry, such as decreased levels of serotonin and norepinephrine, are believed to be responsible for the increased depression. Additionally, benzodiazepines can indirectly worsen mood by worsening sleep (i.e., benzodiazepine-induced sleep disorder). Like alcohol, benzodiazepines can put people to sleep but, while asleep, they disrupt sleep architecture: decreasing sleep time, delaying time to REM sleep, and decreasing deep sleep (the most restorative part of sleep for both energy and mood). Just as some antidepressants can cause or worsen anxiety in some patients due to being activating, benzodiazepines can cause or worsen depression due to being a central nervous system depressant\u2014worsening thinking, concentration and problem solving (i.e., benzodiazepine-induced neurocognitive disorder). However, unlike antidepressants, in which the activating effects usually improve with continued treatment, benzodiazepine-induced depression is unlikely to improve until after stopping the medication.",
            "score": 121.97264099121094
        },
        {
            "docid": "46349526_8",
            "document": "Amita Sehgal . In 2008, Sehgal \"et al.\" discovered the \"sleepless \"gene in fruit flies through insertional mutagenesis. Mutations in the \"sleepless\" gene caused the flies to sleep 80% less than normal flies and live half as long as normal flies. Sehgal \"et al.\" observed flies had extreme loss of sleep when the flies completely lacked the SLEEPLESS protein. Flies with mutations which lowered the level of SLEEPLESS protein had normal levels of sleep, but when the flies were sleep-deprived, they showed abnormal recovery sleep. Sehgal \"et al.\" also found increased stem cell activity within the testes of male flies with mutations in \"sleepless\". The SLEEPLESS protein activates Shaker potassium channels and inhibits nicotinic acetylcholine receptors.",
            "score": 121.33293151855469
        },
        {
            "docid": "674_14",
            "document": "Anatomy . Nervous tissue is composed of many nerve cells known as neurons which transmit information. In some slow-moving radially symmetrical marine animals such as ctenophores and cnidarians (including sea anemones and jellyfish), the nerves form a nerve net, but in most animals they are organized longitudinally into bundles. In simple animals, receptor neurons in the body wall cause a local reaction to a stimulus. In more complex animals, specialized receptor cells such as chemoreceptors and photoreceptors are found in groups and send messages along neural networks to other parts of the organism. Neurons can be connected together in ganglia. In higher animals, specialized receptors are the basis of sense organs and there is a central nervous system (brain and spinal cord) and a peripheral nervous system. The latter consists of sensory nerves that transmit information from sense organs and motor nerves that influence target organs. The peripheral nervous system is divided into the somatic nervous system which conveys sensation and controls voluntary muscle, and the autonomic nervous system which involuntarily controls smooth muscle, certain glands and internal organs, including the stomach.",
            "score": 121.3309097290039
        },
        {
            "docid": "47420086_17",
            "document": "13-Hydroxyoctadecadienoic acid . In guinea pigs, 13(\"S\")-HODE, when injected intravenously, causes a narrowing of lung airways and, when inhaled as an aerosol, mimics the asthmatic hypersensitivity to agents that cause bronchoconstriction by increasing airway narrowing responses to methacholine and histamine. In a mouse model of allergen-induced asthma, 13-HODE levels are elevated, in the latter mouse model, the injection of antibody directed against 13(\"S\")-HODE reduced many of the pathological and physiological features of asthma. mouse forced to overexpress in lung the mouse enzyme (12/15-lipoxygenase) that metabolizes linoleic acid to 13(\"S\")-HODE exhibited elevated levels of this metabolite in lung as well as various pathological and physiological features of asthma, and the instillation of 13(\"S\")HODE replicated many of these features of asthma, In the mouse model of asthma and in the human disease, epithelial cells of lung airways  show various pathological changes including disruption of their mitochondria 13(\"S\")-HODE causes similar disruptive changes in the mitochondria of cultured Beas 2B human airway epithelial cells. Furthermore, human suffers of asthma exhibit increased levels of 13-HODE in their blood, sputum, and washings form their lung alveola (i.e. bronchoalveolar lavage fluid of BAL) and human eosinophils, which are implicated in contributing to human asthma, metabolize linoleic acid to 13-HODE (and 9-HODE) to a far greater extent than any other type of leukocyte. The mechanism responsible for 13-HODE's impact on airway epithelial cells may involve its activation of the TRPV1 receptor (see previous section on TRPV1): this receptor is highly expressed in mouse and human airway epithelial cells and in Beas 2B human airway epithelial cells and, furthermore, suppression of TRPV1 expression as well as a TPRV1 receptor inhibitor (capsazepan) block mouse airway responses to 13(S)-HODE. While much further work is needed, these pre-clinical studies allow that 13(\"S\")-HODE, made at least in part by eosinophils and operating through TRPV1, may be responsible for the airways damage which occurs in the more severe forms of asthma and that pharmacological inhibitors of TRPV1 may eventually proved to be useful additions to the treatment of asthma.",
            "score": 121.2879409790039
        },
        {
            "docid": "21944_3",
            "document": "Nervous system . At the cellular level, the nervous system is defined by the presence of a special type of cell, called the neuron, also known as a \"nerve cell\". Neurons have special structures that allow them to send signals rapidly and precisely to other cells. They send these signals in the form of electrochemical waves traveling along thin fibers called axons, which cause chemicals called neurotransmitters to be released at junctions called synapses. A cell that receives a synaptic signal from a neuron may be excited, inhibited, or otherwise modulated. The connections between neurons can form neural pathways, neural circuits, and larger networks that generate an organism's perception of the world and determine its behavior. Along with neurons, the nervous system contains other specialized cells called glial cells (or simply glia), which provide structural and metabolic support.",
            "score": 121.2476577758789
        },
        {
            "docid": "896294_6",
            "document": "Paul Greengard . Greengard's research has focused on events inside the neuron caused by neurotransmitters. Specifically, Greengard and his fellow researchers studied the behavior of second messenger cascades that transform the docking of a neurotransmitter with a receptor into permanent changes in the neuron. In a series of experiments, Greengard and his colleagues showed that when dopamine interacts with a receptor on the cell membrane of a neuron, it causes an increase in cyclic AMP inside the cell. This increase of cyclic AMP, in turn activates a protein called protein kinase A, which turns other proteins on or off by adding phosphate groups in a reaction known as phosphorylation. The proteins activated by phosphorylation can then perform a number of changes in the cell: transcribing DNA to make new proteins, moving more receptors to the synapse (and thus increasing the neuron's sensitivity), or moving ion channels to the cell surface (and thus increasing the cell's excitability). He was awarded the Nobel Prize in 2000 \"for showing how neurotransmitters act on the cell and can activate a central molecule known as DARPP-32\".",
            "score": 120.59813690185547
        },
        {
            "docid": "36070066_2",
            "document": "Nuocyte . The nuocyte is a cell of the innate immune system that plays an important role in type 2 immune responses that are induced in response to helminth worm infection or in conditions such as asthma and atopic disease. Nuocytes are amongst the first cells activated in type 2 immune responses and are thought to play important roles in activating and recruiting other cells types through their production of type 2 cytokines interleukin 4, 5 and 13. Nuocytes have been observed to proliferate in the presence of IL-7 \"in vitro\". Nuocytes contribute to the expulsion of helminth worms and to the pathology of colitis and allergic airways disease.",
            "score": 120.55411529541016
        },
        {
            "docid": "29940688_7",
            "document": "Effects of parasitic worms on the immune system . In their \"Parasite Immunology\" article on worms and viral infections, Dr. Kamal \"et al.\" explain why some parasitic worms aggravate the immune response. Because parasitic worms often induce Th2 cells and lead to suppressed Th1 cells, problems arise when Th1 cells are needed. Such cases occur with viral diseases. Several examples of viral infections worsened by parasitic worms are described below.",
            "score": 119.89653778076172
        },
        {
            "docid": "29940688_4",
            "document": "Effects of parasitic worms on the immune system . In the past, helminths were thought to simply suppress T-helper Type 1 (Th1) cells while inducing T-helper Type 2 (Th2) cells. Rook points out that this hypothesis would only explain the regulatory effects of parasitic worms on autoimmune diseases caused by Th1 cells. However, helminths also regulate Th2-caused diseases, such as allergy and asthma. Professor Rook postulates that different parasitic worms suppress different Th types, but always in favor of regulatory T (Treg) cells.",
            "score": 119.7237548828125
        },
        {
            "docid": "6019108_13",
            "document": "FLP-FRT recombination . Genetic mosaicism occurs within an organism when similar cell types express different phenotypes due to dissimilar genotypes at specific loci. Simply put, this occurs when one organism contains different genotypes, which is usually rare in nature. However, this can be easily (and problematically) produced using FLP-FRT recombination. If two different FRT sites are present within a cell, and FLP is present in appropriate concentrations, the FRT cassette will continue to be excised and inserted between the two FRT sites. This process will continue until the FLP proteins fall below the required concentrations resulting in cells within an organism possessing different genotypes. This has been seen from fruit flies to mice and is indiscriminate against specific chromosomes (somatic and sex) or cell types (somatic and germline).",
            "score": 119.68892669677734
        }
    ]
}